Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Delaware Entertainment Insider.
Press releases published on August 12, 2025

Chicago Author Lori Orlinsky Releases Second Book in Beloved BEING ME series
CHICAGO, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Yorkshire Publishing proudly announces the release of Being Middle (is a great place to be), the second title in Lori Orlinsky’s award-winning BEING ME series — just in time for National Middle Child Day (August …

Climb Bio Reports Second Quarter 2025 Financial Results and Provides Business Updates
Clinical Trials of Budoprutug in Immune Thrombocytopenia (ITP) and Systemic Lupus Erythematosus (SLE) Underway; Trial of Budoprutug in Primary Membranous Nephropathy (pMN) Expected to Initiate in the Coming Weeks Budoprutug Subcutaneous Formulation …

Quavo Fraud & Disputes Selected to Debut Breakthrough AI Functionality at FinovateFall 2025
WILMINGTON, Del., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Quavo, Inc. (“Quavo”), the leading disputes technology partner and trusted advisor for financial institutions, will unveil enhanced AI capabilities for its flagship dispute management platform, QFD®, live …

China UnionPay's Poetry POS Machine Campaign Goes Global with Debut in Thailand
BANGKOK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Recently, "Poetry Lights the Heart's Lantern" Bangkok lantern and poem festival, a public welfare initiative by China UnionPay under its Poetry POS Machine campaign, kicked off at Iconsiam, Bangkok's landmark …

Selvam Public Affairs Launches to Drive Policy, Funding and Reputation Wins in Canada and the U.S.
TORONTO, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Award-winning public affairs executive and former Google Policy Lead Saeed Selvam today announced the launch of Selvam Public Affairs (SelvamPA), a full-service, cross-border firm helping organizations secure …

Mabylon AG Raises CHF 30 Million to Advance Peanut Allergy Lead Program MY006 to Clinical Proof-of-Concept
Funding combines equity investment and convertible loan Focus on best-in-class, clinical-stage peanut allergen neutralizing antibody Further potential for developing Mabylon’s discovery and pre-clinical pipeline programs Dr. Thomas Hecht has joined Board …